Capital Performance Advisors’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-31
Closed -$104 396
2024
Q3
$104 Buy
+31
New +$104 ﹤0.01% 2689